Evogene (EVGN) Change in Cash (2013 - 2026)
Evogene (EVGN) posted Change in Cash of -$4.4 million for Q1 2026, down 160.64% sequentially from $7.3 million in Q4 2025, and up 43.06% YoY from -$3.1 million in Q1 2025.
Evogene (EVGN) Change in Cash (2013 - 2026) Analysis & Trends
Evogene has reported Change in Cash for 14 years, with the latest figure at -$4.4 million in Q1 2026.
- Quarterly Change in Cash rose 43.06% year-over-year to -$4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 122.99% YoY) and the FY2025 annual result came in at -$2.3 million, up 57.14% from the prior year.
- Change in Cash retreated to -$4.4 million in Q1 2026 per EVGN's latest filing, from $7.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $7.3 million in Q4 2025 and troughed at -$7.8 million in Q1 2025.
- A 5-year average of -$904642.9 and a median of -$2.6 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 273.74% in 2022, then soared 160.74% in 2024.
- Over 5 years, Change in Cash stood at -$2.9 million in 2022, then plunged by 127.74% to -$6.6 million in 2023, then jumped by 160.74% to $4.0 million in 2024, then jumped by 83.99% to $7.3 million in 2025, then tumbled by 160.64% to -$4.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$4.4 million, $7.3 million, and -$2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 | -4.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.45 Mn |
| Dec 31, 2025 | 7.33 Mn |
| Sep 30, 2025 | -2.77 Mn |
| Jun 30, 2025 | 904,000.00 |
| Mar 31, 2025 | -7.81 Mn |
| Dec 31, 2024 | 3.98 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Dec 31, 2023 | -6.56 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | -2.77 Mn |
| Dec 31, 2022 | -2.88 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | -7.15 Mn |
| Dec 31, 2021 | -5.31 Mn |
| Sep 30, 2021 | -5.12 Mn |
| Jun 30, 2021 | 4.11 Mn |
| Mar 31, 2021 | -7.59 Mn |
| Dec 31, 2020 | 4.74 Mn |
| Sep 30, 2020 | 10.42 Mn |